Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scienture Holdings (SCNX) Notes Payables (2016 - 2025)

Scienture Holdings (SCNX) has disclosed Notes Payables for 13 consecutive years, with $2.0 million as the latest value for Q3 2025.

  • Quarterly Notes Payables changed 0.0% to $2.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Sep 2025, changed 0.0% year-over-year, with the annual reading at $2.3 million for FY2024, 4470.85% up from the prior year.
  • Notes Payables hit $2.0 million in Q3 2025 for Scienture Holdings, roughly flat from $2.0 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $5.2 million in Q3 2023 to a low of $50000.0 in Q4 2023.
  • Historically, Notes Payables has averaged $1.3 million across 5 years, with a median of $500000.0 in 2022.
  • Biggest five-year swings in Notes Payables: tumbled 70.0% in 2023 and later soared 4470.85% in 2024.
  • Year by year, Notes Payables stood at $225000.0 in 2021, then dropped by 25.93% to $166667.0 in 2022, then tumbled by 70.0% to $50000.0 in 2023, then skyrocketed by 4470.85% to $2.3 million in 2024, then decreased by 12.49% to $2.0 million in 2025.
  • Business Quant data shows Notes Payables for SCNX at $2.0 million in Q3 2025, $2.0 million in Q2 2025, and $2.0 million in Q1 2025.